HEADER HYDROLASE/HYDROLASE INHIBITOR 05-NOV-07 3B9F TITLE 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTHROMBIN; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: THROMBIN LIGHT CHAIN; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PROTHROMBIN; COMPND 10 CHAIN: H; COMPND 11 FRAGMENT: THROMBIN HEAVY CHAIN; COMPND 12 SYNONYM: COAGULATION FACTOR II; COMPND 13 EC: 3.4.21.5; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: PLASMA SERINE PROTEASE INHIBITOR; COMPND 18 CHAIN: I; COMPND 19 SYNONYM: PROTEIN C INHIBITOR, ACROSOMAL SERINE PROTEASE INHIBITOR, COMPND 20 PLASMINOGEN ACTIVATOR INHIBITOR 3,PAI3,PCI,SERPIN A5; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: F2; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: SERPINA5, PCI, PLANH3, PROCI; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MICHAELIS COMPLEX, ACUTE PHASE, BLOOD COAGULATION, CLEAVAGE ON PAIR KEYWDS 2 OF BASIC RESIDUES, DISEASE MUTATION, GAMMA-CARBOXYGLUTAMIC ACID, KEYWDS 3 GLYCOPROTEIN, HYDROLASE, KRINGLE, PROTEASE, SECRETED, SERINE KEYWDS 4 PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.LI,T.E.ADAMS,J.A.HUNTINGTON REVDAT 6 01-NOV-23 3B9F 1 REMARK HETSYN REVDAT 5 29-JUL-20 3B9F 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 11-APR-18 3B9F 1 COMPND SOURCE REMARK DBREF REVDAT 4 2 1 SEQADV REVDAT 3 13-JUL-11 3B9F 1 VERSN REVDAT 2 24-FEB-09 3B9F 1 VERSN REVDAT 1 22-APR-08 3B9F 0 JRNL AUTH W.LI,T.E.ADAMS,J.NANGALIA,C.T.ESMON,J.A.HUNTINGTON JRNL TITL MOLECULAR BASIS OF THROMBIN RECOGNITION BY PROTEIN C JRNL TITL 2 INHIBITOR REVEALED BY THE 1.6-A STRUCTURE OF THE JRNL TITL 3 HEPARIN-BRIDGED COMPLEX. JRNL REF PROC.NATL.ACAD.SCI.USA V. 105 4661 2008 JRNL REFN ISSN 0027-8424 JRNL PMID 18362344 JRNL DOI 10.1073/PNAS.0711055105 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1049755.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : 95905 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2928 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.70 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 15020 REMARK 3 BIN R VALUE (WORKING SET) : 0.3250 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 460 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5113 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 100 REMARK 3 SOLVENT ATOMS : 523 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.76000 REMARK 3 B22 (A**2) : -0.68000 REMARK 3 B33 (A**2) : -1.08000 REMARK 3 B12 (A**2) : -1.98000 REMARK 3 B13 (A**2) : -2.66000 REMARK 3 B23 (A**2) : 4.78000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.930 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.580 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.390 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 53.15 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIGAND.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : LIGAND.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3B9F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000045244. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.06 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 95914 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 37.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : 0.05200 REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.44500 REMARK 200 R SYM FOR SHELL (I) : 0.44500 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2OL2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11% PEG 3350, 0.12M MGSO4, PH 7.4, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, I, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR L -2 REMARK 465 ALA L -1 REMARK 465 THR L 0 REMARK 465 GLY L 15 REMARK 465 ARG L 16 REMARK 465 TRP H 147A REMARK 465 THR H 147B REMARK 465 ALA H 147C REMARK 465 ASN H 147D REMARK 465 VAL H 147E REMARK 465 GLY H 147F REMARK 465 MET I -7 REMARK 465 GLY I -6 REMARK 465 HIS I -5 REMARK 465 HIS I -4 REMARK 465 HIS I -3 REMARK 465 HIS I -2 REMARK 465 HIS I -1 REMARK 465 HIS I 0 REMARK 465 HIS I 1 REMARK 465 HIS I 2 REMARK 465 HIS I 3 REMARK 465 HIS I 4 REMARK 465 SER I 5 REMARK 465 SER I 6 REMARK 465 GLY I 7 REMARK 465 HIS I 8 REMARK 465 ILE I 9 REMARK 465 ASP I 10 REMARK 465 ASP I 11 REMARK 465 ASP I 12 REMARK 465 ASP I 13 REMARK 465 LYS I 14 REMARK 465 HIS I 15 REMARK 465 MET I 16 REMARK 465 VAL I 17 REMARK 465 GLY I 18 REMARK 465 ALA I 19 REMARK 465 THR I 20 REMARK 465 VAL I 21 REMARK 465 ALA I 22 REMARK 465 PRO I 23 REMARK 465 SER I 24 REMARK 465 SER I 25 REMARK 465 ARG I 26 REMARK 465 ARG I 27 REMARK 465 ASN I 79 REMARK 465 LEU I 80 REMARK 465 GLN I 81 REMARK 465 LYS I 82 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER H 36A OG REMARK 470 LYS H 87 CE NZ REMARK 470 LYS H 110 CD CE NZ REMARK 470 LYS H 145 CD CE NZ REMARK 470 LYS H 149 CG CD CE NZ REMARK 470 ASP H 186A CG OD1 OD2 REMARK 470 LYS H 236 CD CE NZ REMARK 470 LYS H 240 CD CE NZ REMARK 470 ASP I 28 CG OD1 OD2 REMARK 470 SER I 43 OG REMARK 470 SER I 83 OG REMARK 470 LYS I 86 CG CD CE NZ REMARK 470 GLU I 87 CG CD OE1 OE2 REMARK 470 ARG I 90 CG CD NE CZ NH1 NH2 REMARK 470 ASN I 100 CG OD1 ND2 REMARK 470 GLN I 101 CG CD OE1 NE2 REMARK 470 ARG I 103 NE CZ NH1 NH2 REMARK 470 LYS I 162 CG CD CE NZ REMARK 470 LYS I 164 CD CE NZ REMARK 470 ASP I 173 CG OD1 OD2 REMARK 470 LYS I 187 CE NZ REMARK 470 LYS I 197 CG CD CE NZ REMARK 470 SER I 208 OG REMARK 470 GLU I 209 CG CD OE1 OE2 REMARK 470 ARG I 229 CG CD NE CZ NH1 NH2 REMARK 470 GLN I 241 CG CD OE1 NE2 REMARK 470 ASN I 243 CG OD1 ND2 REMARK 470 LYS I 266 CD CE NZ REMARK 470 ARG I 269 CG CD NE CZ NH1 NH2 REMARK 470 LYS I 273 CD CE NZ REMARK 470 LYS I 286 CE NZ REMARK 470 ARG I 342 CG CD NE CZ NH1 NH2 REMARK 470 THR I 347 OG1 CG2 REMARK 470 ARG I 386 CD NE CZ NH1 NH2 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ALA I 346 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO H 186 C - N - CA ANGL. DEV. = 14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE L 7 -87.73 -132.07 REMARK 500 SER H 36A 76.02 32.96 REMARK 500 TYR H 60A 91.15 -160.56 REMARK 500 ASN H 60G 75.45 -156.15 REMARK 500 HIS H 71 -51.27 -127.86 REMARK 500 ASN H 78 -1.80 60.14 REMARK 500 ILE H 79 -56.40 -134.97 REMARK 500 GLU H 97A -69.19 -122.20 REMARK 500 LYS H 185 -132.96 11.33 REMARK 500 PRO H 186 -8.55 -46.24 REMARK 500 ASP H 186A 64.90 -113.02 REMARK 500 GLU H 186B -22.98 -148.13 REMARK 500 SER H 214 -128.41 -113.13 REMARK 500 SER I 66 -140.94 48.16 REMARK 500 SER I 84 145.09 -172.66 REMARK 500 PRO I 102 80.42 -56.63 REMARK 500 ASP I 104 72.89 -56.55 REMARK 500 SER I 146 -72.13 -41.12 REMARK 500 LYS I 187 109.46 -166.02 REMARK 500 ARG I 219 119.02 -175.37 REMARK 500 ASP I 221 -177.82 -174.57 REMARK 500 SER I 232 63.06 65.99 REMARK 500 GLN I 241 99.16 -63.28 REMARK 500 ASN I 322 49.14 -92.60 REMARK 500 ALA I 344 85.57 58.49 REMARK 500 ALA I 345 176.37 173.76 REMARK 500 ALA I 346 -151.88 36.46 REMARK 500 THR I 347 -163.12 69.08 REMARK 500 ASP I 375 -116.40 -123.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH L 80 DISTANCE = 6.07 ANGSTROMS REMARK 525 HOH L 488 DISTANCE = 7.01 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 SGN B 1 REMARK 610 IDS B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OL2 RELATED DB: PDB REMARK 900 NATIVE PCI REMARK 900 RELATED ID: 2HI9 RELATED DB: PDB REMARK 900 NATIVE PCI REMARK 999 REMARK 999 SEQUENCE REMARK 999 NATURAL VARIANT AT THIS POSITION DBREF 3B9F L -2 16 UNP P00734 THRB_HUMAN 315 363 DBREF 3B9F H 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 3B9F I 17 387 UNP P05154 IPSP_HUMAN 36 406 SEQADV 3B9F ALA H 195 UNP P00734 SER 568 ENGINEERED MUTATION SEQADV 3B9F MET I -7 UNP P05154 EXPRESSION TAG SEQADV 3B9F GLY I -6 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I -5 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I -4 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I -3 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I -2 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I -1 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I 0 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I 1 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I 2 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I 3 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I 4 UNP P05154 EXPRESSION TAG SEQADV 3B9F SER I 5 UNP P05154 EXPRESSION TAG SEQADV 3B9F SER I 6 UNP P05154 EXPRESSION TAG SEQADV 3B9F GLY I 7 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I 8 UNP P05154 EXPRESSION TAG SEQADV 3B9F ILE I 9 UNP P05154 EXPRESSION TAG SEQADV 3B9F ASP I 10 UNP P05154 EXPRESSION TAG SEQADV 3B9F ASP I 11 UNP P05154 EXPRESSION TAG SEQADV 3B9F ASP I 12 UNP P05154 EXPRESSION TAG SEQADV 3B9F ASP I 13 UNP P05154 EXPRESSION TAG SEQADV 3B9F LYS I 14 UNP P05154 EXPRESSION TAG SEQADV 3B9F HIS I 15 UNP P05154 EXPRESSION TAG SEQADV 3B9F MET I 16 UNP P05154 EXPRESSION TAG SEQADV 3B9F ASN I 45 UNP P05154 SER 64 SEE SEQUENCE DETAILS SEQRES 1 L 49 THR ALA THR SER GLU TYR GLN THR PHE PHE ASN PRO ARG SEQRES 2 L 49 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 3 L 49 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 4 L 49 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 H 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 H 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 H 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 H 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 H 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 H 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP ALA GLY GLY PRO SEQRES 17 H 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 I 395 MET GLY HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS SER SEQRES 2 I 395 SER GLY HIS ILE ASP ASP ASP ASP LYS HIS MET VAL GLY SEQRES 3 I 395 ALA THR VAL ALA PRO SER SER ARG ARG ASP PHE THR PHE SEQRES 4 I 395 ASP LEU TYR ARG ALA LEU ALA SER ALA ALA PRO SER GLN SEQRES 5 I 395 ASN ILE PHE PHE SER PRO VAL SER ILE SER MET SER LEU SEQRES 6 I 395 ALA MET LEU SER LEU GLY ALA GLY SER SER THR LYS MET SEQRES 7 I 395 GLN ILE LEU GLU GLY LEU GLY LEU ASN LEU GLN LYS SER SEQRES 8 I 395 SER GLU LYS GLU LEU HIS ARG GLY PHE GLN GLN LEU LEU SEQRES 9 I 395 GLN GLU LEU ASN GLN PRO ARG ASP GLY PHE GLN LEU SER SEQRES 10 I 395 LEU GLY ASN ALA LEU PHE THR ASP LEU VAL VAL ASP LEU SEQRES 11 I 395 GLN ASP THR PHE VAL SER ALA MET LYS THR LEU TYR LEU SEQRES 12 I 395 ALA ASP THR PHE PRO THR ASN PHE ARG ASP SER ALA GLY SEQRES 13 I 395 ALA MET LYS GLN ILE ASN ASP TYR VAL ALA LYS GLN THR SEQRES 14 I 395 LYS GLY LYS ILE VAL ASP LEU LEU LYS ASN LEU ASP SER SEQRES 15 I 395 ASN ALA VAL VAL ILE MET VAL ASN TYR ILE PHE PHE LYS SEQRES 16 I 395 ALA LYS TRP GLU THR SER PHE ASN HIS LYS GLY THR GLN SEQRES 17 I 395 GLU GLN ASP PHE TYR VAL THR SER GLU THR VAL VAL ARG SEQRES 18 I 395 VAL PRO MET MET SER ARG GLU ASP GLN TYR HIS TYR LEU SEQRES 19 I 395 LEU ASP ARG ASN LEU SER CYS ARG VAL VAL GLY VAL PRO SEQRES 20 I 395 TYR GLN GLY ASN ALA THR ALA LEU PHE ILE LEU PRO SER SEQRES 21 I 395 GLU GLY LYS MET GLN GLN VAL GLU ASN GLY LEU SER GLU SEQRES 22 I 395 LYS THR LEU ARG LYS TRP LEU LYS MET PHE LYS LYS ARG SEQRES 23 I 395 GLN LEU GLU LEU TYR LEU PRO LYS PHE SER ILE GLU GLY SEQRES 24 I 395 SER TYR GLN LEU GLU LYS VAL LEU PRO SER LEU GLY ILE SEQRES 25 I 395 SER ASN VAL PHE THR SER HIS ALA ASP LEU SER GLY ILE SEQRES 26 I 395 SER ASN HIS SER ASN ILE GLN VAL SER GLU MET VAL HIS SEQRES 27 I 395 LYS ALA VAL VAL GLU VAL ASP GLU SER GLY THR ARG ALA SEQRES 28 I 395 ALA ALA ALA THR GLY THR ILE PHE THR PHE ARG SER ALA SEQRES 29 I 395 ARG LEU ASN SER GLN ARG LEU VAL PHE ASN ARG PRO PHE SEQRES 30 I 395 LEU MET PHE ILE VAL ASP ASN ASN ILE LEU PHE LEU GLY SEQRES 31 I 395 LYS VAL ASN ARG PRO MODRES 3B9F ASN H 60G ASN GLYCOSYLATION SITE HET NAG A 1 14 HET FUC A 2 10 HET SGN B 1 16 HET IDS B 2 15 HET SO4 H 781 5 HET GOL H 782 6 HET GOL H 3 6 HET GOL H 4 6 HET SO4 I 388 5 HET SO4 I 389 5 HET GOL I 390 6 HET GOL I 391 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D-GLUCOPYRANOSE HETNAM IDS 2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN SGN N,O6-DISULFO-GLUCOSAMINE; 6-O-SULFO-N-SULFO-ALPHA-D- HETSYN 2 SGN GLUCOSAMINE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D- HETSYN 3 SGN GLUCOSE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-D-GLUCOSE; HETSYN 4 SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-GLUCOSE HETSYN IDS O2-SULFO-GLUCURONIC ACID; 2-O-SULFO-ALPHA-L-IDURONIC HETSYN 2 IDS ACID; 2-O-SULFO-L-IDURONIC ACID; 2-O-SULFO-IDURONIC HETSYN 3 IDS ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 NAG C8 H15 N O6 FORMUL 4 FUC C6 H12 O5 FORMUL 5 SGN C6 H13 N O11 S2 FORMUL 5 IDS C6 H10 O10 S FORMUL 6 SO4 3(O4 S 2-) FORMUL 7 GOL 5(C3 H8 O3) FORMUL 14 HOH *523(H2 O) HELIX 1 1 ASN L 1K GLY L 1F 1 6 HELIX 2 2 PHE L 7 SER L 11 5 5 HELIX 3 3 THR L 14B TYR L 14J 1 9 HELIX 4 4 ALA H 55 CYS H 58 5 4 HELIX 5 5 PRO H 60B ASP H 60E 5 4 HELIX 6 6 THR H 60I ASN H 62 5 3 HELIX 7 7 ASP H 125 LEU H 130 1 9 HELIX 8 8 GLU H 164 SER H 171 1 8 HELIX 9 9 LEU H 234 GLY H 246 1 13 HELIX 10 10 ASP I 28 ALA I 41 1 14 HELIX 11 11 SER I 49 SER I 61 1 13 HELIX 12 12 LEU I 62 ALA I 64 5 3 HELIX 13 13 GLY I 65 LEU I 76 1 12 HELIX 14 14 SER I 84 LEU I 99 1 16 HELIX 15 15 GLN I 123 LEU I 135 1 13 HELIX 16 16 ASP I 145 THR I 161 1 17 HELIX 17 17 LYS I 255 LEU I 263 1 9 HELIX 18 18 SER I 264 PHE I 275 1 12 HELIX 19 19 GLU I 296 GLY I 303 5 8 HELIX 20 20 SER I 305 THR I 309 5 5 SHEET 1 A 7 SER H 20 ASP H 21 0 SHEET 2 A 7 GLN H 156 PRO H 161 -1 O VAL H 157 N SER H 20 SHEET 3 A 7 LYS H 135 GLY H 140 -1 N VAL H 138 O VAL H 158 SHEET 4 A 7 PRO H 198 LYS H 202 -1 O VAL H 200 N ARG H 137 SHEET 5 A 7 TRP H 207 VAL H 213 -1 O TYR H 208 N MET H 201 SHEET 6 A 7 GLY H 226 HIS H 230 -1 O THR H 229 N ILE H 212 SHEET 7 A 7 MET H 180 ALA H 183 -1 N PHE H 181 O TYR H 228 SHEET 1 B 7 LYS H 81 SER H 83 0 SHEET 2 B 7 LEU H 64 ILE H 68 -1 N ILE H 68 O LYS H 81 SHEET 3 B 7 GLN H 30 ARG H 35 -1 N PHE H 34 O LEU H 65 SHEET 4 B 7 GLU H 39 LEU H 46 -1 O LEU H 41 N LEU H 33 SHEET 5 B 7 TRP H 51 THR H 54 -1 O LEU H 53 N SER H 45 SHEET 6 B 7 ALA H 104 LEU H 108 -1 O MET H 106 N VAL H 52 SHEET 7 B 7 LEU H 85 ILE H 90 -1 N TYR H 89 O LEU H 105 SHEET 1 C 2 LEU H 60 TYR H 60A 0 SHEET 2 C 2 LYS H 60F ASN H 60G-1 O LYS H 60F N TYR H 60A SHEET 1 D 7 ILE I 46 PHE I 48 0 SHEET 2 D 7 ILE I 378 VAL I 384 -1 O LYS I 383 N ILE I 46 SHEET 3 D 7 PHE I 369 VAL I 374 -1 N PHE I 369 O VAL I 384 SHEET 4 D 7 THR I 245 PRO I 251 -1 N LEU I 247 O PHE I 372 SHEET 5 D 7 CYS I 233 PRO I 239 -1 N VAL I 238 O ALA I 246 SHEET 6 D 7 VAL I 211 ASP I 228 -1 N LEU I 226 O VAL I 235 SHEET 7 D 7 GLN I 200 TYR I 205 -1 N GLN I 202 O VAL I 214 SHEET 1 E 8 ILE I 46 PHE I 48 0 SHEET 2 E 8 ILE I 378 VAL I 384 -1 O LYS I 383 N ILE I 46 SHEET 3 E 8 PHE I 369 VAL I 374 -1 N PHE I 369 O VAL I 384 SHEET 4 E 8 THR I 245 PRO I 251 -1 N LEU I 247 O PHE I 372 SHEET 5 E 8 CYS I 233 PRO I 239 -1 N VAL I 238 O ALA I 246 SHEET 6 E 8 VAL I 211 ASP I 228 -1 N LEU I 226 O VAL I 235 SHEET 7 E 8 LYS I 276 PRO I 285 -1 O LEU I 280 N ASP I 221 SHEET 8 E 8 GLN I 361 VAL I 364 1 O GLN I 361 N GLU I 281 SHEET 1 F 5 ASP I 137 THR I 141 0 SHEET 2 F 5 LEU I 108 ASP I 117 1 N THR I 116 O THR I 141 SHEET 3 F 5 VAL I 178 PHE I 186 -1 O ILE I 179 N PHE I 115 SHEET 4 F 5 GLU I 327 VAL I 336 1 O VAL I 329 N ASN I 182 SHEET 5 F 5 PHE I 287 GLN I 294 -1 N PHE I 287 O VAL I 336 SHEET 1 G 2 TRP I 190 THR I 192 0 SHEET 2 G 2 GLY I 340 ARG I 342 1 O THR I 341 N TRP I 190 SSBOND 1 CYS L 1 CYS H 122 1555 1555 2.03 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.02 SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.03 SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.03 LINK ND2 ASN H 60G C1 NAG A 1 1555 1555 1.45 LINK O6 NAG A 1 C1 FUC A 2 1555 1555 1.40 LINK O4 SGN B 1 C1 IDS B 2 1555 1555 1.43 CISPEP 1 SER H 36A PRO H 37 0 0.01 CISPEP 2 LYS H 185 PRO H 186 0 0.28 CRYST1 44.055 48.825 97.850 78.72 81.52 77.69 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022699 -0.004951 -0.002582 0.00000 SCALE2 0.000000 0.020963 -0.003616 0.00000 SCALE3 0.000000 0.000000 0.010485 0.00000